"Glutamates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure.
| Descriptor ID |
D005971
|
| MeSH Number(s) |
D12.125.067.625 D12.125.119.409
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glutamates".
Below are MeSH descriptors whose meaning is more specific than "Glutamates".
This graph shows the total number of publications written about "Glutamates" by people in this website by year, and whether "Glutamates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 1 | 1 |
| 2004 | 3 | 1 | 4 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 1 | 3 |
| 2007 | 5 | 2 | 7 |
| 2008 | 3 | 4 | 7 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 3 | 5 |
| 2011 | 0 | 5 | 5 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 2 | 3 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glutamates" by people in Profiles.
-
Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome. Pediatr Neurol. 2024 Mar; 152:63-72.
-
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat Med. 2023 Jun; 29(6):1468-1475.
-
Biological embedding of early trauma: the role of higher prefrontal synaptic strength. Eur J Psychotraumatol. 2023; 14(2):2246338.
-
Loss of functional System x-c uncouples aberrant postnatal neurogenesis from epileptogenesis in the hippocampus of Kcna1-KO mice. Cell Rep. 2022 11 22; 41(8):111696.
-
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial. JAMA Oncol. 2022 10 01; 8(10):1411-1418.
-
PHLPP Inhibitor NSC74429 Is Neuroprotective in Rodent Models of Cardiac Arrest and Traumatic Brain Injury. Biomolecules. 2022 09 23; 12(10).
-
The solute carrier family 7 member 11 (SLC7A11) is regulated by LH/androgen and required for cystine/glutathione homeostasis in mouse Sertoli cells. Mol Cell Endocrinol. 2022 06 01; 549:111641.
-
Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemp Clin Trials. 2022 03; 114:106704.
-
NMDA receptor-independent LTP in mammalian nervous system. Prog Neurobiol. 2021 05; 200:101986.
-
Phenotypic variation of transcriptomic cell types in mouse motor cortex. Nature. 2021 10; 598(7879):144-150.